Neovii, Tel Aviv University partner for COVID-19 vaccine

By The Science Advisory Board staff writers

May 13, 2020 -- Israeli firm Ramot has inked a license agreement with Neovii, a Swiss-based biopharmaceutical company, for the research and development of a COVID-19 vaccine.

Ramot is Tel Aviv University's technology transfer company. University researchers have been working with coronaviruses for over 15 years, and shortly after SARS-CoV-2 emerged they began reconstituting a receptor binding motif as the basis for a new vaccine.

Under the agreement, Neovii will hold exclusive rights to develop and commercialize an epitope-based vaccine platform for the rapid discovery of a novel COVID-19 vaccine. The vaccine under development aims to reconstruct the coronavirus's receptor binding motif within the spike protein. The company will work to manufacture and deliver a commercial product to the general population on an accelerated timeline.

NIH leadership discusses COVID-19 vaccine collaborations
Public-private partnerships could help meet the unprecedented need to manufacture and distribute safe and effective COVID-19 vaccines around the globe,...
ABL Europe to manufacture Themis SARS-CoV-2 vaccine in France
Biopharmaceutical company Themis and contract development and manufacturing organization ABL Europe announced that they have signed an agreement to manufacture...
Inovio expands manufacturing for COVID-19 vaccine
Inovio has partnered with German contract manufacturer Richter-Helm BioLogics to produce large-scale quantities of Inovio's investigational DNA vaccine.

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter